Adleap 160mg Tablet

About

Adleap 160mg Tablet is an Angiotensin Receptor Blocker (ARB), a class of medications primarily utilized in the treatment of high blood pressure (hypertension) and chronic heart failure. Its mechanism of action involves selectively blocking the binding of angiotensin II to its specific AT1 receptors located in various tissues, including blood vessels, the heart, and kidneys. Angiotensin II is a powerful hormone that triggers vasoconstriction, leading to elevated blood pressure and increased cardiac strain. By preventing this binding, Adleap facilitates the relaxation and dilation of blood vessels, which consequently lowers blood pressure and alleviates the burden on the heart. ARBs are often chosen as an alternative for patients who experience a persistent dry cough, a common side effect associated with ACE inhibitors, offering a well-tolerated option for effective cardiovascular management and protection.

Uses

• Management of essential hypertension.
• Treatment of heart failure.
• Reduction of cardiovascular risk in high-risk patients.
• Protection against kidney damage in type 2 diabetes.

Directions For Use

Take one tablet orally once daily, with or without food, as prescribed by your healthcare provider.

Benefits

• Effectively lowers elevated blood pressure.
• Reduces the risk of stroke and heart attack.
• Improves symptoms and prognosis in heart failure.
• Provides renal protection in diabetic patients.
• Lower incidence of dry cough compared to ACE inhibitors.
• Well-suited for long-term management of chronic conditions.

Side Effects

• Dizziness
• Lightheadedness
• Fatigue
• Headache
• Nausea
• Diarrhea
• Hypotension
• Hyperkalemia
• Back pain
• Upper respiratory tract infection
• Renal impairment
• Angioedema (rare)

Safety Measures

• Alcohol - Alcohol can potentiate the hypotensive effects of Adleap, increasing the risk of dizziness or fainting. It is best to consume alcohol in moderation or avoid it.
• Pregnancy - Adleap is contraindicated during pregnancy, especially in the second and third trimesters, due to significant risks of fetal injury and death.
• Breastfeeding - It is generally not recommended to use Adleap while breastfeeding as it may be excreted in breast milk. Consult your doctor for alternatives.
• Liver - Use with caution in patients with hepatic impairment. Dosage adjustments may be necessary, and liver function should be monitored.
• Kidney - Patients with renal impairment should use Adleap with caution. Regular monitoring of kidney function and serum potassium levels is essential.
• Lung - Adleap is generally not associated with lung-related side effects like cough, making it an alternative for patients intolerant to ACE inhibitors.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.